Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933855 · ClinicalTrials.gov registry record
Patient Communication Training Intervention
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT00933855: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00933855 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00933855 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to test a class for Queens Cancer Center patients. We want to find out if patients think this program is helpful.
Interventions
- BEHAVIORAL Questionnaires and training workshop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-06 |
What the finished NCT00933855 record still lists
NCT00933855 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires and training workshop is the first listed.
NCT00933855 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00933855 about?
NCT00933855 is a clinical study titled "Patient Communication Training Intervention". The purpose of this study is to test a class for Queens Cancer Center patients. We want to find out if patients think this program is helpful.
What is the current status of trial NCT00933855?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2009-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00933855?
The interventions under investigation include: Questionnaires and training workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT00933855?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia